Kiwi Biosciences

Patent-pending enzymes to break down common dietary triggers

HealthcareConsumer Health and WellnessBiotechFood Tech https://www.fodzyme.com ↗

Company facts

Early-stage
Founded
2021
Employees
10
Headquarters
United States

About

Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.